Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Share-based Compensation (2016 - 2025)

Vanda Pharmaceuticals' Share-based Compensation history spans 16 years, with the latest figure at $2.3 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 20.19% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.5 million, a 23.79% decrease, with the full-year FY2025 number at $9.5 million, down 23.79% from a year prior.
  • Share-based Compensation hit $2.3 million in Q4 2025 for Vanda Pharmaceuticals, up from $2.1 million in the prior quarter.
  • Over the last five years, Share-based Compensation for VNDA hit a ceiling of $4.8 million in Q1 2022 and a floor of $2.1 million in Q2 2025.
  • Historically, Share-based Compensation has averaged $3.4 million across 5 years, with a median of $3.4 million in 2023.
  • Biggest five-year swings in Share-based Compensation: rose 26.03% in 2021 and later decreased 29.58% in 2025.
  • Tracing VNDA's Share-based Compensation over 5 years: stood at $3.8 million in 2021, then grew by 0.24% to $3.8 million in 2022, then decreased by 13.48% to $3.3 million in 2023, then dropped by 12.53% to $2.9 million in 2024, then dropped by 20.19% to $2.3 million in 2025.
  • Business Quant data shows Share-based Compensation for VNDA at $2.3 million in Q4 2025, $2.1 million in Q3 2025, and $2.1 million in Q2 2025.